跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,263 条关于
“CBX-663”
全部
3,263
临床试验
2,069
药物
922
机构
14
资讯
258
9天前
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of First-in-Class T-Cell Engager CBX-663
6个月前
Crossbow Therapeutics Secures $77 Million Series B to Advance TCR-Mimetic Cancer Immunotherapies
去年
Cybrexa Therapeutics Doses First Patient in Phase 2 Ovarian Cancer Trial with CBX-12
去年
Viva Biotech Portfolio Companies Achieve Clinical Milestones in Diabetes, Gout, Obesity, Cancer, and Stroke
6年前
Advances and Challenges in Gynecologic Cancer Treatment
去年
Cybrexa's Novel Peptide-Drug Conjugates Show Promising Tumor-Selective Activity in Preclinical Studies
3年前
Tailored Axillary Surgery: A Novel Approach for Clinically Node-Positive Breast Cancer
去年
First US Nasal COVID-19 Vaccine Shows 67% Infection Reduction in Phase 1 Trial
3个月前
AI-Powered Billing Tools Drive Healthcare Costs to 17-Year High, PwC Report Finds
6个月前
InMed Pharmaceuticals Winds Down BayMedica Operations to Focus on CB1/CB2 Receptor Drug Pipeline
第 1 页,共 26 页
上一页
下一页